SynBiotic SE (SBX.DE)

EUR 3.08

(-1.6%)

Long Term Debt Summary of SynBiotic SE

  • SynBiotic SE's latest annual long term debt in 2023 was 2.89 Million EUR , down -18.49% from previous year.
  • SynBiotic SE's latest quarterly long term debt in 2023 FY was 2.89 Million EUR , down -18.49% from previous quarter.
  • SynBiotic SE reported annual long term debt of 3.54 Million EUR in 2022, up 278.44% from previous year.
  • SynBiotic SE reported annual long term debt of 938.01 Thousand EUR in 2021, up 272.23% from previous year.
  • SynBiotic SE reported quarterly long term debt of - EUR for 2023 Q2, down -100.0% from previous quarter.
  • SynBiotic SE reported quarterly long term debt of 3.54 Million EUR for 2022 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SynBiotic SE (2023 - 2018)

Historical Annual Long Term Debt of SynBiotic SE (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 2.89 Million EUR -18.49%
2022 3.54 Million EUR 278.44%
2021 938.01 Thousand EUR 272.23%
2020 252 Thousand EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%

Peer Long Term Debt Comparison of SynBiotic SE

Name Long Term Debt Long Term Debt Difference
MPH Health Care AG 8.33 Million EUR 65.279%
Apontis Pharma AG 6 Million EUR 51.776%
Dermapharm Holding SE 950.7 Million EUR 99.696%
Evotec SE 477.11 Million EUR 99.394%
MERCK Kommanditgesellschaft auf Aktien 8.84 Billion EUR 99.967%
PharmaSGP Holding SE 65.37 Million EUR 95.574%